[ad_1]
In recent years, oncology has been marked by many innovations for better patient care, including, in particular: immunotherapy. From now on, the treatments want to be more and more “personalized” and we are also talking about precision medicine. In addition, the route of treatment combinations is very promising. Explanations from Prof. Dominique Bellet, Emeritus Professor of Immunology – Paris Cité University and member of the Board of Directors of Companies Against Cancer.
[ad_2]
